bpc 157 and cancer cells Cretostimogene expanded access program for BCG-unresponsive #BladderCancer. Sarah Psutka, MD, MSc Fred Hutch joins Sam Chang, MD, MBA Vanderbilt Health to discuss how the oncolytic immunotherapy AXP-BPC-157+TB500 (Wolverine Blend) – Type:Dark Chocolate Catalog-Ref: 16516
Pay in 4 interest-free payments of $5.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27